JPMorgan Finds No Benefits From COVID Lockdown
While the latest vaccine progress news out of Pfizer was welcome by the market (and its CEO who sold over 60% of his PFE stock on the day of the announcement) in a week where global infection resurgence continued with cases jumping 8% W/W last week (537k vs. 309k in Aug-Oct) and EU/ UK re-imposed …